Clinical Trials Browser

Phase 2 × Propranolol × Breast × Clear all

NCT05741164 2026-06-04

Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer

Phase 2 Recruiting

Triple Negative Breast Neoplasms

NCT01847001 2021-09-10

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Phase 2 Completed

10 enrolled 12 charts

Breast Neoplasms

NCT02596867 2018-03-01

NPBC

Phase 2 Terminated

2 enrolled 5 charts

Breast Neoplasms